Leutero 50mg Injection
| Product Name | Leutero Injection |
|---|---|
| Strength | 50 mg |
| Active Ingredient | Leuprolide Acetate |
| Drug Class | GnRH Agonist |
| Form | Injection |
| Route of Administration | Intramuscular / Subcutaneous (as prescribed) |
| Packaging | Single-use vial / prefilled syringe (as per manufacturer) |
| Storage Condition | Store at 2°C–8°C, protect from light |
| Prescription Required | Yes |
| Usage | Prostate cancer, breast cancer, endometriosis, fibroids |
Leutero 50mg Injection
Leutero 50mg Injection contains Leuprolide Acetate, a gonadotropin-releasing hormone (GnRH) agonist indicated for the treatment of prostate cancer, breast cancer, endometriosis, uterine fibroids, and precocious puberty. It helps manage hormone-dependent conditions by regulating the levels of sex hormones in the body.
Leuprolide works by temporarily suppressing the production of testosterone and estrogen, which can slow the growth of hormone-sensitive cancers and other related conditions. Leutero 50 mg Injection is administered under strict medical supervision to ensure safety and effectiveness.
Leutero 50mg Injection is provided through a trusted pharmaceutical distribution network. The product is handled according to proper storage and quality standards to maintain safety, potency, and dependable availability.
Product Features
- Long-acting GnRH agonist injection
- Contains Leuprolide Acetate 50 mg
- Used in hormone-dependent cancers and disorders
- Effective testosterone and estrogen suppression
- Administered by trained healthcare professionals
- Suitable for hospital and clinical use
- Manufactured under GMP standards
- Prescription-required medicine
How It Helps
- Suppresses testosterone and estrogen production in the body
- Slows the growth of hormone-dependent cancers and disorders
- Helps manage symptoms of endometriosis and uterine fibroids
- Regulates precocious puberty by controlling early hormone levels
Reviews
There are no reviews yet.